Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference
Globe Newswire (Tue, 30-Dec 4:05 PM ET)
Market Chameleon (Fri, 19-Dec 4:47 AM ET)
Globe Newswire (Thu, 18-Dec 4:05 PM ET)
Medline Inc provides medical-surgical products and supply chain solutions for various healthcare settings. Its offerings include med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. It serves hospitals, surgery centers, physician offices, and post-acute care facilities, supporting patient care needs. The company operates in two segments: Medline Brand and Supply Chain Solutions. The company's revenues are generated principally from the sale of its surgical products.
Medline - Class A trades on the NASDAQ stock market under the symbol MDLN.
As of January 8, 2026, MDLN stock price climbed to $41.25 with 4,139,590 million shares trading.
MDLN has a market cap of $32.47 billion. This is considered a Large Cap stock.
The top ETF exchange traded funds that MDLN belongs to (by Net Assets): FPX, TCAF, SCHG, SCHX, ITOT.
MDLN support price is $38.79 and resistance is $42.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDLN shares will trade within this expected range on the day.